Ablacon Leadership

Since May 2015 Ablacon Inc.

From April 2013 Executive Director Corporate Development, and later CEO Sophono Inc. Boulder (CO). Sold Sophono Inc. to Medtronic in April 2015.

From March 2010 to November 2012, CEO of Valtronic Group

January 2009 to February 2010 partner at Patrimonium Medical Technology Advisors AG, Baar.

Since 1999 Private Equity Investor and founder of several companies. 2001 to 2009 investment partner for the L-Bank of Baden Württemberg. Active Chairman and Restructuring Manager of Seleon GmbH, Greenovation GmbH and Flyion GmbH. Before Professor of Biophysics and Physiology, University of Tübingen. In 1991 Member of Nobel Prize winning Max-Planck-Institute team (single channel recording from neurons). Inventor of a novel therapeutic principle (Treatment of Tinnitus).

Specialties: Medical Technologies.

Josef Koblish is a Chief Strategy Officer at Ablacon Inc.

Doug Koo is a Managing Director at EP Map Gmbh, Managing Director and Chief Financial Officer at Ajax Health, and Chief Financial Officer at Verix Health and is based in Santa Clara, California. He has worked as Chief Financial Officer at TauTona Group, CFO at Everypath, and Managing Director at Leader Ventures. Douglas studied at Stanford Graduate School of Business between 1990 and 1992 and UC San Diego between 1982 and 1986.

Medical device professional focused on advancing patient care through innovation. Focused on the convergence of unmet clinical needs, new gadgets and compelling business models.

Since May 2015 Ablacon Inc.

From April 2013 Executive Director Corporate Development, and later CEO Sophono Inc. Boulder (CO). Sold Sophono Inc. to Medtronic in April 2015.

From March 2010 to November 2012, CEO of Valtronic Group

January 2009 to February 2010 partner at Patrimonium Medical Technology Advisors AG, Baar.

Since 1999 Private Equity Investor and founder of several companies. 2001 to 2009 investment partner for the L-Bank of Baden Württemberg. Active Chairman and Restructuring Manager of Seleon GmbH, Greenovation GmbH and Flyion GmbH. Before Professor of Biophysics and Physiology, University of Tübingen. In 1991 Member of Nobel Prize winning Max-Planck-Institute team (single channel recording from neurons). Inventor of a novel therapeutic principle (Treatment of Tinnitus).

Specialties: Medical Technologies.

Josef Koblish is a Chief Strategy Officer at Ablacon Inc.

Doug Koo is a Managing Director at EP Map Gmbh, Managing Director and Chief Financial Officer at Ajax Health, and Chief Financial Officer at Verix Health and is based in Santa Clara, California. He has worked as Chief Financial Officer at TauTona Group, CFO at Everypath, and Managing Director at Leader Ventures. Douglas studied at Stanford Graduate School of Business between 1990 and 1992 and UC San Diego between 1982 and 1986.